115 related articles for article (PubMed ID: 19773140)
41. Incidence and mortality of pancreatic cancer in the Nordic countries 1971-2000.
Nagenthiraja K; Ewertz M; Engholm G; Storm HH
Acta Oncol; 2007; 46(8):1064-9. PubMed ID: 17952708
[TBL] [Abstract][Full Text] [Related]
42. Pancreatic cancer in West Virginia: results from a rural academic medical center.
Yu A; Somasundar P; Povoski SP; McFadden DW
W V Med J; 2002; 98(4):146-8. PubMed ID: 12206067
[TBL] [Abstract][Full Text] [Related]
43. [Incidence and prevalence estimations for breast and colorectal cancer in the Picardy region].
Peng J; Ganry O; Tramier B; Dubreuil A; Raverdy N; Thulliez A;
Rev Epidemiol Sante Publique; 2002 Oct; 50(5):427-32. PubMed ID: 12471335
[TBL] [Abstract][Full Text] [Related]
44. Differences in survival by histologic type of pancreatic cancer.
Fesinmeyer MD; Austin MA; Li CI; De Roos AJ; Bowen DJ
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1766-73. PubMed ID: 16030115
[TBL] [Abstract][Full Text] [Related]
45. Pancreatic carcinoma: reappraisal of surgical experiences in one Japanese university hospital.
Yamaguchi K; Shimizu S; Yokohata K; Noshiro H; Chijiiwa K; Tanaka M
Hepatogastroenterology; 1999; 46(30):3257-62. PubMed ID: 10626197
[TBL] [Abstract][Full Text] [Related]
46. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
[TBL] [Abstract][Full Text] [Related]
47. Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study.
Thomassen I; Lemmens VE; Nienhuijs SW; Luyer MD; Klaver YL; de Hingh IH
Pancreas; 2013 Jan; 42(1):72-5. PubMed ID: 22850624
[TBL] [Abstract][Full Text] [Related]
48. Trends in the incidence and management of biliary tract cancer: a French population-based study.
Lepage C; Cottet V; Chauvenet M; Phelip JM; Bedenne L; Faivre J; Bouvier AM
J Hepatol; 2011 Feb; 54(2):306-10. PubMed ID: 21056501
[TBL] [Abstract][Full Text] [Related]
49. Long-term trends in the incidence and relative survival of pancreatic cancer in Canada: A population-based study.
Akhtar-Danesh GG; Finley C; Akhtar-Danesh N
Pancreatology; 2016; 16(2):259-65. PubMed ID: 26804003
[TBL] [Abstract][Full Text] [Related]
50. Pancreatic Adenocarcinoma in the Finistère Area, France, Between 2002 and 2011 (1002 Cases): Population Characteristics, Treatment and Survival.
Arnachellum RP; Cariou M; Nousbaum JB; Jezequel J; Le Reste JY; Robaszkiewicz M
Pancreas; 2016 Aug; 45(7):953-60. PubMed ID: 26765965
[TBL] [Abstract][Full Text] [Related]
51. Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands.
Haj Mohammad N; Bernards N; Besselink MG; Busch OR; Wilmink JW; Creemers GJ; De Hingh IH; Lemmens VE; van Laarhoven HW
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1353-60. PubMed ID: 26995276
[TBL] [Abstract][Full Text] [Related]
52. Socioeconomic status impacts survival and access to resection in pancreatic adenocarcinoma: A high-resolution population-based cancer registry study.
Thobie A; Mulliri A; Dolet N; Eid Y; Bouvier V; Launoy G; Alves A; Dejardin O
Surg Oncol; 2018 Dec; 27(4):759-766. PubMed ID: 30449504
[TBL] [Abstract][Full Text] [Related]
53. The current state of pancreatic cancer in Canada: incidence, mortality, and surgical therapy.
Hurton S; MacDonald F; Porter G; Walsh M; Molinari M
Pancreas; 2014 Aug; 43(6):879-85. PubMed ID: 24763076
[TBL] [Abstract][Full Text] [Related]
54. Pancreatic cancer epidemiology and survival in an Australian population.
Luke C; Price T; Karapetis C; Singhal N; Roder D
Asian Pac J Cancer Prev; 2009; 10(3):369-74. PubMed ID: 19640175
[TBL] [Abstract][Full Text] [Related]
55. Epidemiology of pancreatic cancer in France: descriptive study from the French national hospital database.
Maire F; Cibot JO; Compagne C; Hentic O; Hammel P; Muller N; Ponsot P; Levy P; Ruszniewski P
Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):904-908. PubMed ID: 28471829
[TBL] [Abstract][Full Text] [Related]
56. Focus on an unusual rise in pancreatic cancer incidence in France.
Bouvier AM; Uhry Z; Jooste V; Drouillard A; Remontet L; Launoy G; Leone N;
Int J Epidemiol; 2017 Dec; 46(6):1764-1772. PubMed ID: 28605500
[TBL] [Abstract][Full Text] [Related]
57. Incidence of pancreatic cancer in Denmark: 70 years of registration, 1943-2012.
Weble TC; Bjerregaard JK; Kissmeyer P; Vyberg M; Hansen CP; Holländer NH; Johansen C
Acta Oncol; 2017 Dec; 56(12):1763-1768. PubMed ID: 28741399
[TBL] [Abstract][Full Text] [Related]
58. Pancreatic cancer in sweden 1980-2000: a population-based study of hospitalized patients concerning time trends in curative surgery and other interventional therapies.
Linder S; Boström L; Nilsson B
J Gastrointest Surg; 2006 May; 10(5):672-8. PubMed ID: 16713540
[TBL] [Abstract][Full Text] [Related]
59. Incidence, diagnostic, treatment and outcome of patients diagnosed with cancer of the pancreas during 1986-2009: a population-based study.
Jonsdottir SB; Juliusson G; Kristinsson JÖ; Hreinsson JP; Jonasson JG; Björnsson ES
Scand J Gastroenterol; 2018 Jan; 53(1):100-106. PubMed ID: 29058490
[TBL] [Abstract][Full Text] [Related]
60. Underestimation of pancreatic cancer in the national cancer registry - Reconsidering the incidence and survival rates.
Fest J; Ruiter R; van Rooij FJ; van der Geest LG; Lemmens VE; Ikram MA; Coebergh JW; Stricker BH; van Eijck CH
Eur J Cancer; 2017 Feb; 72():186-191. PubMed ID: 28033529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
